These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 10690611
21. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier JL, Niaudet P, Morinet F, Le Deist F, Fischer AM, Griscelli C. N Engl J Med; 1991 May 23; 324(21):1451-6. PubMed ID: 2023604 [Abstract] [Full Text] [Related]
22. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC. J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157 [Abstract] [Full Text] [Related]
23. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute. Hou HA, Yao M, Tang JL, Chen YK, Ko BS, Huang SY, Tien HF, Chang HH, Lu MY, Lin TT, Lin KH, Hsiao CH, Lin CW, Chen YC. Bone Marrow Transplant; 2009 Feb 20; 43(4):315-21. PubMed ID: 18836488 [Abstract] [Full Text] [Related]
24. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Rohr JC, Wagner HJ, Lauten M, Wacker HH, Jüttner E, Hanke C, Pohl M, Niemeyer CM. Pediatr Transplant; 2008 Jun 20; 12(4):426-31. PubMed ID: 18466428 [Abstract] [Full Text] [Related]
25. Long-term survival after post-transplant lymphoproliferative disease in children. Nathanson S, Debray D, Delarue A, Deschênes G. Pediatr Nephrol; 2002 Aug 20; 17(8):668-72. PubMed ID: 12185479 [Abstract] [Full Text] [Related]
27. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation. Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, Lee CG, Bridges K, Parrish RS, Henslee-Downey PJ. Bone Marrow Transplant; 2001 Dec 20; 28(12):1117-23. PubMed ID: 11803352 [Abstract] [Full Text] [Related]
28. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality. Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS. J Pediatr Surg; 2008 Dec 20; 43(12):2174-7. PubMed ID: 19040929 [Abstract] [Full Text] [Related]
29. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI. N Engl J Med; 1990 Dec 20; 323(25):1723-8. PubMed ID: 2100991 [Abstract] [Full Text] [Related]
36. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Picarsic J, Jaffe R, Mazariegos G, Webber SA, Ellis D, Green MD, Reyes-Múgica M. Cancer; 2011 Oct 01; 117(19):4540-50. PubMed ID: 21446044 [Abstract] [Full Text] [Related]
37. [Lymphoproliferative lesions localized in the renal graft. A French multicenter study]. Renoult E, Kessler M. J Radiol; 1994 Jan 01; 75(1):53-6. PubMed ID: 8151542 [Abstract] [Full Text] [Related]
38. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease. Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B. J Med Virol; 2008 Mar 01; 80(3):441-54. PubMed ID: 18205222 [Abstract] [Full Text] [Related]